1H MR spectroscopy monitoring of changes in choline peak area and line shape after Gd-contrast administration

Magnetic Resonance Imaging

Volumn 16, Issue 10, 1998, Pages 1273-1280

  Sijens, Paul E ^a   Oudkerk, Matthijs ^a   Dijk, Pieter Van ^a   Levendag, Peter C ^a   Vecht, Charles J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Brain tumors; Gd contrast agent; Magnetic resonance spectroscopy

Indexed keywords

CHOLINE; GADOLINIUM; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR DIAGNOSIS; BRAIN; GLIOMA; INSTRUMENTATION; METABOLISM; METASTASIS; METHODOLOGY; MIDDLE AGED; NORMAL DISTRIBUTION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; STATISTICS; TIME;

ADULT; AGED; BRAIN; BRAIN NEOPLASMS; CHOLINE; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NORMAL DISTRIBUTION; TIME FACTORS;

EID: 0032217171     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(98)00143-X     Document Type: Article

References (19)

1. 1H Chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast agent. Magn. Reson. Med. 37:1997;222-225.
2. Bruhn H., Frahm J., Gyngell M.L., Merbold K.D., Hänicke W., Sauter R., Hamburger C. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo Initial experience in patients with cerebral tumors . Radiology. 172:1989;541-548.
3. 1H spectroscopic imaging. Magn. Reson. Med. 13:1990;62-76.
4. Luyten P.R., Marien A.J.H., Heindel W., van Gerwen P.H.J., Herholz K., den Hollander J.A. Metabolic imaging of patients with intracranial tumors H-1 MR spectroscopic imaging and PET . Radiology. 176:1990;791-799.
5. Gill S.S., Thomas D.G.T., Van Bruggen N., Gadian D.G., Peden C.J., Bell J.D., Cox I.J., Menon D.K., Iles R.A., Bryant D.J., Coutts G.A. Proton MR spectroscopy of intracranial tumours in vivo and in vitro studies . J. Comput. Assist. Tomogr. 14:1990;497-504.
6. Arnold D.L., Shoubridge E.A., Villemure J.-G., Feindel W. Proton and phosphorus magnetic resonance specroscopy of human astrocytomas in vivo; preliminary observations of tumor grading. NMR Biomed. 3:1990;184-189.
7. Alger J.R., Frank J.A., Bizzi A., Fulham M.J., DeSouza B.X., Duhaney M.O., Inscoe S.W., Black J.L., van Zijl P.C.M., Moonen C.T.W., Di Chiro G. Metabolism of human gliomas assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET . Radiology. 177:1990;633-641.
8. 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J. Comput. Assist. Tomogr. 15:1991;67-76.
9. Kugel H., Heindel W., Ernestus R.-I., Bunke J., du Mesnil R., Friedmann G. Human brain tumors Spectral patterns detected with localized H-1 MR spectroscopy . Radiology. 183:1992;701-709.
10. Fulham M.J., Bizzi A., Dietz M.J., Shih H.H.-L., Raman R., Sobering G.S., Frank J.A., Dwyer A.J., Alger J.R., Di Chiro G. Mapping of brain tumor metabolites with proton MR spectroscopic imaging Clinical relevance . Radiology. 185:1992;675-686.
11. Ott D., Hennig J., Ernst T. Human brain tumors Assessment with in vivo proton MR spectroscopy . Radiology. 186:1993;745-752.
12. 1H MR spectroscopy in patients with metastatic brain tumors A multi-center study . Magn. Reson. Med. 33:1995;818-826.
13. 1H NMR spectroscopy in vivo and in vitro . J. Comp. Assist. Tomogr. 18:1994;705-713.
14. Sijens P.E., van Dijk P., Oudkerk M. Correlation between choline level and Gd-DTPA enhancement in patients with brain metastases of mammary carcinoma. Magn. Reson. Med. 32:1994;549-555.
15. Sijens P.E., Vecht Ch.J., Levendag P.C., van Dijk P., Oudkerk M. Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer. Unexpected inverse correlation between the changes in tumor choline level and post-gadolinium MRI contrast. Invest. Radiol. 30:1995;738-744.
16. Negendank W.G., Sauter R., Brown T.R., et al. Proton magnetic resonance spectroscopy in patients with glial tumors A multicenter study . J. Neurosurg. 84:1996;449-458.
17. Sijens P.E., Oudkerk M. MR Spectroscopy. Andrä W., Nowak J.H. Magnetism in Medicine. 1998;356-378 John Wiley & Sons Ltd, Chichester.
18. Taylor, J.S.; Reddick, W.E.; Kingsley, P.B.; Ogg, R.J. Proton MRS after gadolinium contrast agent. In: Proc., SMR, 3rd Annual Meeting, Nice. Berkeley, CA: Society of Magnetic Resonance; 1995: p. 1854.
19. Narayana P.A., Wolinsky J.S., Jackson E.F., McCarthy M. Proton MR spectroscopy of gadolinium-enhanced multiple sclerosis plaques. J. Magn. Reson. Imaging. 2:1992;263-270.